(1 - 6 from 8
)
Cleveland BioLabs Announces Start of Advanced Cancer Trial for ...
www.globenewswire.com
"We are delighted to begin this first study with CBLB502 in cancer patients," stated Yakov Kogan, Ph.D., MBA, interim Chief Executive Officer of Cleveland BioLabs. "This trial is an important step in the development of a product ...
Cleveland BioLabs Announces Science Publication on Molecular ...
www.globenewswire.com
Yakov Kogan, PhD, interim Chief Executive Officer of Cleveland BioLabs, commented: "Selection of this work for publication in this highly prestigious journal indicates the significance of the findings, the complexity of the ...
Cleveland BioLabs Announces Compensation Reductions for Co-Founders...
www.globenewswire.com
... Chief Executive Officer, Yakov Kogan and Chief Scientific Officer, Andrei Gudkov and the Company's directors have voluntarily reduced their ...
Cleveland BioLabs Announces Management Reorganization
www.globenewswire.com
Yakov Kogan, Ph.D., MBA, the current Chief Operating Officer of the Company, has also been appointed interim Chief Executive Officer and will ...
sorted by relevance / date